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Abstract
Deep vein thrombosis (DVT) is an often underdiagnosed disease that can be life threatening for
individuals. Currently, the best practice approach to assess the risk of venous thromboembolism
(VTE) in patients within a rehabilitation hospital is unknown. We examined how well the
Caprini risk assessment (CRA) score predicts VTE events (deep vein thrombosis (DVT),
pulmonary embolism (PE)) within an inpatient rehabilitation hospital. Between January 2015 and
October 2020, VTE events, the CRA Score, and risk factors were collected from a chart review
conducted at Mary Free Bed Rehabilitation Hospital (MFB) among 3,091 patients. Results from
the unadjusted logistic regression model showed that patients who have scores in the moderaterisk (odds ratios (OR)=0.076; 95% confidence interval (CI): 0.010-0.587) and high-risk
categories (OR=0.961; 95% CI: 0.476-1.943) have lower odds of being diagnosed with DVT or
PE. The highest risk category ( ≥ 5) showed an association between the CRA score and DVT or
PE (OR=1.031; 95% CI: 0.540-1.967). When adjusting for medical service and discharge
location, findings were similar among all four risk categories. The area under the receiver
operating characteristic (ROC) curve, was 0.57 for the unadjusted model and increased to 0.61
for the adjusted model. Although a small association between the CRA score and prediction of
VTE was noted, the low incidence of these events in the patient population limited study sample
size and precision. This may be because almost all patients were on prophylaxis medication.
Keywords: Deep vein thrombosis, Venous thromboembolism, Pulmonary Embolism, Caprini risk
assessment, Rehabilitation
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Background
Evaluating the Caprini Risk Assessment in an Inpatient Rehabilitation Facility
Deep vein thrombosis (DVT) is an often underdiagnosed disease and can be life
threatening for individuals. DVT is a medical condition that occurs when a blood clot forms in a
deep vein, typically developing in the lower leg, thigh, pelvis, or arm. While half of individuals
have no symptoms at all, the most common symptoms of DVT are swelling, pain, tenderness,
and redness of the skin (Centers for Disease Control and Prevention [CDC], 2020a). Risk factors
for developing DVT include injury to a vein, slow blood flow, and certain chronic medical
conditions, such as heart disease, lung disease, cancer, and inflammatory bowel disease (CDC,
2020a). The most serious complications of DVT happen when a part of the clot breaks off and
travels through the bloodstream to the lungs, causing a blockage called a pulmonary embolism
(PE) and if the clot is large enough it can stop blood from reaching the lungs causing death
(CDC, 2020a). Venous thromboembolism (VTE), which includes PE and DVT, can occur in
both the upper and lower extremities of the body (Yamashita et al., 2019). Upper extremity DVT
is less common than lower extremity DVT, but it is still an area of concern especially with
patients who have a central venous catheter, a higher rate of active cancer, or a recent
hospitalization (Ageno et al., 2019). Additionally, it is well established that DVT of the lower
extremities is common following major orthopedic surgeries to repair hip, knee, and spinal
injuries since ambulation is difficult (Zixuan et al., 2020).
The exact number of individuals in the United States (U.S.) affected by DVT is unknown
as no population-based registries for DVT exist, although as many as 900,000 people could be
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affected each year. Of those, roughly 100,000 will die due to improper DVT detection, leading
to a PE, and ultimately death (CDC, 2020a). Sudden death is the first symptom in about 25% of
people who have PE and approximately 10 to 30% of people will die within one month of
diagnosis (CDC, 2020b). Among people who have had DVT, one third to one half will have
long-term complications, such as post-thrombotic syndrome which includes symptoms of
swelling, pain, discoloration, and scaling of the affected limb (CDC, 2020b). Many health care
facilities measure thigh and calf circumference to predict complications of a DVT. Other
approaches include specific risk assessments, such as the Caprini scale. Additionally, a D-dimer
blood test has also been used to predict DVT. The diagnosis of DVT relies heavily on the use of
objective tests because the signs and symptoms are not specific. Venography and other forms of
ultrasonography are used in patients with clinically suspected DVT but are limited by the
requirement for serial testing if the initial test is normal as well as by false positive results (Wells
et al., 2005). False positive results have led to potentially unneeded procedures causing an extra
burden on patients and healthcare professionals, as well as the economy due to unnecessary
health care costs. Prediction and diagnosis of DVT are both important to determine within
patients. Accurate and timely prediction of DVT enables non-invasive approaches to be
implemented to avoid adverse outcomes associated with DVT. In summary, there is a critical
need to accurately predict patients at risk of DVT to improve diagnosis and appropriate treatment
for DVT and ultimately prevent VTE.

EVALUATING THE CAPRINI RISK ASSESSMENT

6

DVT Prediction
Caprini Risk Assessment
The Caprini risk assessment (CRA) has been evaluated in studies to see if there is a
correlation between CRA scores and the incidence of DVT. Lobastov et al. (2015;2016)
examined a group of high-risk patients who underwent abdominal (48%) or cranial and/or spinal
(52%) surgery and found DVT in 28% of patients. The incidence of DVT was 2% in patients
with a CRA score of 5 to 8, 26% in patients with a score of 9 to 11, and 65% in patients with a
score of 12 to 15. The risk for DVT was increased 18.7-fold for patients with scores of 9 to 11
and 98.4-fold for scores of 12 to 15 compared with patients with scores of 5 to 8.
The CRA was also used to evaluate risk stratification for DVT among a sample of
bedridden patients in 25 hospitals in China over 9 months (Bo et al., 2020). While a low overall
incidence of 0.9% was found, risk by CRA score varied by classification group. More
specifically, compared with the low-risk group, risk was 2.10-fold greater in the moderate-risk
group, 3.34-fold greater in the high-risk group, and 16.12-fold greater in the highest-risk group
with CRA score ≥ 9 (Bo et al., 2020). This demonstrates that the CRA can be effectively used to
stratify patients into DVT risk categories, based on individual risk factors.
VTE can be a common and devastating postoperative complication. Hatchey et al. (2016)
evaluated the CRA in postoperative patients, demonstrating that this high-risk patient population
was more likely to have VTE. Based on the CRA protocol, those who are considered high-risk
were prescribed postoperative prophylaxis medication and adherence to outcome audits were
measured. A total of 126 patients were included with 24 patients scoring high-risk (19.2%), 60
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were moderate-risk (48.0%), and 41 scored low-risk (32.8%). Patient adherence to postdischarge prophylaxis medication was 97.2% and the overall VTE was 2.3%, with no postdischarge VTEs or adverse bleeding events.
The CRA has also been compared to other prediction tools to see which method is more
accurate when diagnosing DVT. Chen et al. (2018) reviewed data from a sample of hospitalized
patients to compare the performance of the CRA and Padua risk assessments. The Padua risk
assessment includes eleven items focusing on past medical history risk factors, age, and weight.
Results showed that the CRA had a higher sensitivity (0.738 vs. 0.421) but a lower specificity
(0.647 vs. 0.925) than the Padua risk assessment. The area under curve (AUC) value of the CRA
(0.779 + 0.029) is significantly higher than the value of Padua risk assessment (0.635 + 0.031),
which shows that the CRA has a better predictive ability for all patient data (Chen et al., 2018).
Although the specificity of the Padua risk assessment was higher than the CRA, this study
demonstrates that the CRA was significantly superior to the Padua model based on sensitivity
and prediction of DVT in patients. DVT can lead to fatal consequences which stresses the
importance of risk assessment models to screen high-risk patients.
Calf Measurements
Some DVT prediction techniques include calf measurements as a factor but many others
do not. Calf measurements can be useful when diagnosing patients with symptomatic DVT.
Research has shown that using a D-dimer test in addition to measuring an individual’s calf can
help diagnosis or rule out DVT. Johanning et al. (2012) prospectively evaluated patients that
were suspected of DVT by collecting data that assessed characteristics to include and exclude
proximal DVT. Results showed that out of the 156 patients that were enrolled, elevated D-dimer
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levels (> 0.5 nanograms/milliliter) were observed in 22 of the patients diagnosed with DVT,
which yielded a sensitivity of 95% and negative predictive value of 99%. Symptoms of swelling
or pain were present in 94% of all patients and asymmetric calf swelling of more than 2.0
centimeters (cm) was noted in 14 of the patients.
Calf measurements are usually taken upon admission to healthcare facilities, depending
on risk factors and symptoms. Ng et al. (2019) aimed to see if calf measurements at admission to
an inpatient rehabilitation unit would have an impact on DVT detection. A total of 373 patients
were admitted to the inpatient rehabilitation unit during a year. Collected measurements included
compliance (if a calf measurement was recorded), if there was a difference of greater than 3 cm
between two calves, if a venous doppler ultrasound was ordered for the affected leg, and if the
outcome of the doppler study was positive. Only 6 patients (1.6%) did not have calves measured,
achieving 98.4% compliance to measurement of calves by the admitting nurse. Only 1 patient
had a difference in calf measurement and clinical exam significant to refer the patient for a
doppler ultrasound. When the patient was further examined, results showed negative findings for
DVT. Calf measurements alone may be a useful approach to screen for DVT in symptomatic
patients. However, accuracy is limited, and additional measures need to be incorporated to
predict and diagnosis DVT. Further, compliance throughout inpatient rehabilitation facilities and
hospitals is extremely important, especially within high-risk populations.
When using simple methods with less information, such as only calf measurements to
rule out DVT, missing data methods can be important to consider. Janssen et al. (2010) evaluated
data in a sample of 804 patients who were suspected of having DVT. Only three variables were
used to predict the presence of DVT; D-dimer level, difference in calf circumference, and history
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of leg trauma. Multiple imputation for missing data at random (ranging from 10% to 90%) was
used. This approach showed less bias within the three variables and increased statistical power
than complete case analysis, which did not include D-dimer levels in the analysis. While calf
measurements are a way to predict DVT outcomes, this technique, in addition to a risk
assessment scale or D-dimer, is needed to properly score patients risk of DVT.
Risk Factors
Research has identified many risk and protective factors for DVT that can be used to
identify at-risk populations. Injury to a vein, often caused by fractures, severe injury, or major
surgery (particularly involving the abdomen, pelvis, hip, and legs) is one of the most common
factors contributing to DVT (CDC, 2020a). Furthermore, slow blood flow is also a common risk
factor. This could be caused by confinement to bed (due to a medical condition or after surgery),
limited movement (having an injured limb), sitting for a long time, and paralysis. Similar for
many disorders, previous diagnosis, family history, age, and/or obesity may also impact risk of
DVT. The chance increases even more for someone who has more than one of these factors at
the same time (CDC, 2020a).
Inpatient Rehabilitation
The diagnosis and treatment of DVT is important not only in acute-care hospitals, but
also, in rehabilitation hospitals. Almost all individuals who are receiving care at an inpatient
rehabilitation hospital have one or more of the risk factors for DVT. Research studies have
shown that DVT often occurs at rehabilitation hospitals within a few weeks of hospitalization,
which could be because DVT is carried over from acute-care hospitals (Wada et al., 2013). A
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proper technique for DVT screening on admission to a rehabilitation hospital is useful for risk
management.
Many patients are transferred to inpatient rehabilitation facilities on DVT prophylaxis,
but protection is not always guaranteed. Patel et al. (2017) identified the incidence of DVT in
high-risk patients who were already on DVT prophylaxis in an inpatient rehabilitation hospital.
A retrospective chart review was used to find the patient’s location of DVT, which was
determined by venous doppler. Prophylactic measures prior to DVT development, patient’s acute
rehabilitation diagnosis, and measures taken once DVT was discovered were all recorded. A
total of 22 patients admitted to the inpatient rehabilitation hospital developed DVT while on
prophylaxis. Distribution of location of DVT included 13 patients with left lower extremity
DVT, 8 patients with right lower extremity DVT, and 2 patients with unknown location of DVT.
Even though patients are placed on DVT prophylaxis before being transferred from acute
hospitals to inpatient rehabilitation hospitals, they are still at risk of developing DVT regardless
of commonly used prophylactic medications. High-risk patients include those both post-stroke
and post-orthopedic procedures, indicated that screening tools and risk assessments would still
be valuable to manage the diagnosis of DVT (Patel et al., 2017).
While treatment for DVT is straightforward, the prevention process remains
controversial. Zorowitz et al. (2005) launched the Post-Stroke Rehabilitation Outcomes Project
(PSROP) database that was used to describe incidence, sequence, and trends in the prevention of
DVT at a rehabilitation hospital. Of the 1,161 patients in the PSROP database, 383 (32.99%)
patients without DVT and 8 (0.69%) with DVT had no documented orders for anticoagulant
medications or any prophylaxis measures at all. Additionally, 65 (5.60%) patients had DVTs
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during their stay at the inpatient rehabilitation. Of 10 (0.86%) patients with DVTs in the common
femoral vein, 4 (40%) were diagnosed within 24 hours of admission, and 9 (90%) of these 10
patients were classified as moderate or severe strokes. Since DVT is common at inpatient
rehabilitation facilities, it is important for clinicians to learn and apply effective treatment
protocols to prevent DVT events to allow more quality time for rehabilitation services.
The long-standing tradition at Mary Free Bed Rehabilitation Hospital (MFB) is to predict
risk of complications from DVT by measuring the patient’s thigh and calf circumference. This is
done upon admission by a Registered Nurse or nurse technician. The patient’s leg circumference
is measured to determine if there is an increase greater than 2.5 cm between the two limbs. A
difference in more than 2.5 cm requires an ultrasound and referral for treatment. This traditional
practice has resulted in many false positives, which negatively impacts MFB patients and
contributes to avoidable health care costs, ultimately adding unnecessary burden on providers
and patients.
Prior research indicates that the CRA is a validated clinical prediction tool used to
diagnose DVT. The CRA incorporates information based on patient medical history and includes
age and weight as a factor. In addition to thigh and calf circumference measurements upon
admission, MFB providers currently use the CRA. Once a risk score is generated from the
assessment, a proper treatment option is determined for moderate, high-risk, and highest-risk
DVT patients.
DVT is quite common within the U.S. population, especially within hospitals and
inpatient rehabilitation facilities. National guidelines, as well as the Joint Commission and
Centers for Medicaid and Medicare Services, have endorsed assessing DVT in medical patients
using various risk assessment models (Grant et al., 2016). While there are many different
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prevention measures and precautions for DVT, health care facilities need to use the most
accurate diagnosis approach to best guide appropriate measures to be implemented to reduce
morbidity and mortality due to DVT.
A linear association between the CRA and DVT detection have been found in previous
literature (Chen et al. 2018, Hatchey et al., 2016, Bo et al., 2020). However, previous studies in
non-intensive care settings have been limited by small sample size. The large inpatient
population at MFB presents a unique opportunity to evaluate the accuracy of DVT prediction
methods and diagnosis among patients referred from acute-care hospitals. These patients may
have been immobilized longer and have greater lengths of stay, putting them at higher risk for
DVT. We evaluated the association of the CRA score and DVT/PE events among 3,091 inpatient
individuals from MFB. The aim of this study was to determine the prediction accuracy of the
CRA score alone and with additional clinical variables, such as medical service unit within the
hospital and discharge location.
Methods
Study Design and Population
We conducted a retrospective chart review using the electronic medical records at MFB.
The inclusion criteria for our study consisted of patients admitted to MFB for inpatient
rehabilitation between 2015-2020. Patients from this chart review were also aged 18 and older.
The original number of patients assessed in this chart review was 10,782 individuals. The CRA
score is calculated within the patient’s chart and nurses are not obligated to fill out the risk
factors that apply to each of the patients. Based on this protocol, there were 7,691 patients
missing a CRA score. Due to this, we removed those patients for a better generalizable sample
size of 3,091 individuals.
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Medical Record Abstraction
The DVT chart review included various patient characteristics relating to factors that
coincide with risk of DVT. Variables for this study included currently receiving prophylaxis,
medications ordered or received, diagnosis of DVT or PE, medical service, discharge location,
receiving anticoagulation, and CRA score (0-20). Diagnosis of DVT or PE is made by a
physician after a patient receives a doppler, ultrasound, or computerized axial tomography scan.
Clinical data was collected through a standardized data pull process used at MFB by trained
medical abstractors.
Predictors and Covariates
The CRA scores were used as the predictor variable. CRA scores can range from 1-20,
depending on patient risk factors. For the purpose of this study, we categorized the cut-points for
these scores as follows: 0-1 (low risk), 2 (moderate risk), 3-4 (high risk), ≥ 5 (highest risk). This
risk assessment and procedure is used by clinicians at MFB and aligns with cut-points from
previous literature (Grant et al., 2016).
Covariates of interest for this study include receiving prophylaxis (yes/no), medications
ordered or received (enoxaparin, aprixaban, heparin, warfarin, rivaroxaban, or none), diagnosis
of DVT or PE (DVT, PE, or neither), medical service (spinal, stroke, orthopedics, cardiac, brain
injury, other), discharge location (home, home with health care, acute-care hospital, other), and
receiving anticoagulation medication (yes/no). Receiving prophylaxis included medication and
compression devices, such as thromboembolism-deterrent (TED) stockings and sequential
compression device (SCDs).
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Outcomes
Our outcome variable of interest was the clinical event of DVT or PE. We categorized
this variable as DVT, PE, or neither. DVT and PE events are diagnosed by doppler, ultrasound or
computerized axial tomography scan. DVT prophylaxis used to prevent these outcomes includes
an algorithm used by physicians and nurses. The algorithm is associated with each patient’s risk
score. If a patient is considered low risk (0-1), they are encouraged to ambulate. If a patient is
considered to be moderate, high, or highest risk, the patient is given a certain pharmacological
anticoagulation. If the patient is unable to receive anticoagulation medication due to a current
contradiction (active/recent bleeding), mechanical prophylaxis is recommended (TEDs, SCDs).
Once the contradiction is resolved, patients are then ordered anticoagulation medications. For
those at highest risk, mechanical prophylaxis as well as anticoagulation medications are highly
advised. For a confirmed diagnosed of DVT or PE, the patient is assessed to see if they require
transfer to acute-care for venodynamic stabilization or imitation of thrombolytic therapy. If the
patient is stable, they will remain in the inpatient rehabilitation facility and receive
pharmacologic anticoagulation.
Statistical Analysis
Descriptive statistics were used to obtain the percentage and frequency of patients who
had DVT, PE, the CRA scores, and the other covariates. We looked at the overall distributions
and then distributions by the study outcome. We used binary logistic regression to estimate odds
ratios (ORs) and 95% confidence intervals (CIs) for each clinical predicator and the CRA score.
We then determined factors that best predict the odds of accuracy for the use of the CRA score.
A receiver operating characteristic curve (ROC) was used to determine the specificity and
sensitivity of the current risk assessment method used at MFB. One participant missing medical
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service and three participants missing discharge location were excluded from the logistic
regression models and ROC curves. All analyses were performed using SAS 9.4. P-values less
than 0.05 and confidence intervals containing 1.0 were considered statistically significant.
Results
Between January 2015 and October 2020, data on 3,091 eligible patients from MFB were
collected. Based on the location and medical service within the hospital, most patients were
located in the spinal injury unit (n=672, 21.75%), stroke unit (n=645, 20.87%), and the brain
injury unit (n=330, 5.34%). In addition, many patients were receiving prophylaxis (n=3048,
98.61%) and receiving anticoagulants (n=2654, 85.86%) (Table A1).
A DVT event occurred in 66 patients while a PE event occurred in 16 patients. Among
those who were diagnosed with DVT many were in the spinal injury unit (n=16, 24.25%) or
other unit (n=32, 46.42%) with similar results for those who had PE. The most common
anticoagulant medications administered to patients with DVT or PE was found to be enoxaparin,
warfarin, and heparin. Results for discharge location among patients with DVT or PE were found
to be similar among both diagnoses. Patients with DVT were most likely to be discharged home
with health care (n=27, 40.52%) or discharged home without health care (n=21, 31.82%). Those
diagnosed with PE were most likely discharged home with health care (n=6, 37.50%) or
discharged to an acute-care hospital (n=5, 31.25%). Receiving prophylaxis and anticoagulation
medications rates were extremely high for both DVT and PE patients. Results from the CRA
score show that most patients diagnosed with DVT had a risk score ≥ 5 (n=36, 54.55%) and
patients diagnosed with PE had a risk score of 2 (n=8, 50.00%) or 0-1 (n=5, 31.25%) (Table
A2).
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Results from the unadjusted logistic regression model showed that patients who have
CRA scores in the moderate-risk (OR=0.076; 95% CI: 0.010-0.587) and high-risk categories
(OR=0.961; 95% CI: 0.476-1.943) have lower odds of being diagnosed with DVT or PE (Table
A3). CRA scores that were among the highest-risk category (≥ 5 scores) showed an association
between the assessment model and a DVT or PE event, but this was not statistically significant
(OR=1.031; 95% CI: 0.540-1.967). While results showed a small association, the ROC graph
from the unadjusted model showed low accuracy with the CRA diagnosing DVT/PE (AUC=
0.5707) (Figure A1). Furthermore, results also showed both low sensitivity (54.9%) and
specificity for the CRA (53.4%).
When adjusting for medical service and discharge location, findings were similar among
all four risk categories (Table A4). Moderate-risk (OR=0.073; 95% CI: 0.009-0.565), highrisk, (OR=0.922; 95% CI: 0.451-1.882) and highest-risk (OR=0.983; 95% CI: 0.983-1.899)
categories were found to have lower odds of being diagnosed with DVT or PE when compared to
the low-risk category (0-1). CRA scores that were among the highest-risk category (≥ 5) showed
an association between the assessment model and predicting DVT or PE, but this was also not
statistically significant (OR=1.031; 95% CI: 0.540-1.967). Similarly, the ROC graph from the
adjusted model still showed low overall accuracy, but AUC results increased to 0.6139 and
sensitivity was 60.9%, while specificity was 43.6% (Figure 2A).
Discussion
Summary of Results
In this study of 3,091 inpatient rehabilitation patients at MFB hospital, we found that the
CRA was associated with predicting DVT or PE in the moderate-risk category, but other categories
were not statistically significant. When adjusting for medical service unit and discharge location,
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similar results were found, where DVT or PE in the moderate-risk category was found to be the
only statistically significant category. Almost all patients who were diagnosed with DVT or PE
were found to be on a prophylaxis or anticoagulation medication. The overall diagnostic accuracy
of the CRA in both unadjusted and adjusted models was low and due to small sample size,
precision was also limited.
Comparison to Previous Literature
Prophylaxis use has become a standard of care at MFB for nearly all inpatient admissions,
regardless of diagnosis. However, prophylaxis use is not a metric within the CRA and confounds
the diagnostic accuracy of this assessment when screening for high-risk individuals for DVT.
Similar results were found in a retrospective dataset analysis among hip fracture patients where
confounding variables associated with receipt of extended DVT prophylaxis may have influenced
the study outcomes (Durand et al., 2018). This study indicated that confounders may have been
related to preoperative patient comorbidity status, and that patients receiving extended DVT
prophylaxis were generally healthier at baseline (Durand et al., 2018). In the study conducted by
Bahl et al. (2010), pharmacologic prophylaxis increased as patient risk increased and results
showed that adherence to the prophylaxis guidelines protected patients from VTE, but effect was
not statistically significant. This may be because type and frequency but not the duration of
prophylaxis was included in the model. However, after adjusting for prophylaxis, the mean
probability of VTE doubles when risk level increased from moderate to high and from high to
highest. This may have been the case for our study, but we were unable to adjust for prophylaxis
given that almost all study participants used prophylaxis.
Descriptive results showed that patients located in the SCI unit had higher rates of DVT
event (24.25%) compared to other units in the hospital. On average, SCI patients at MFB have
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the longest length of stay, which is roughly 4-6 weeks, where stroke patients typically have a
significantly shorter length of stay (7-10 days). Studies have shown that DVT can develop within
7.5 ± 2.2 days in patients with SCI and that DVT occurs more often with a more severe paralysis
(Matsumoto et al., 2015; Piran & Schulman, 2016). This research demonstrates symptomatic
DVT is a frequent complication with SCI patients, which make up most of the patient population
in inpatient rehabilitation hospitals.
According to Portney and Watkins (2015), “The ROC curve is plotted on a square with
values of 1.0 for sensitivity and 1- specificity at the upper left and lower right corners, respectively.
A perfect test instrument will have a true positive rate of 1.0 and a false positive rate of zero,
resulting in a curve that essentially fills the square. A non-informative curve occurs when the true
positive and false positive rates are equal, which means that the test provides no better information
than a 50:50 chance”. At MFB, the AUC threshold for acceptable used is 0.70, with a positive
likelihood ratio over 5 and a negative likelihood ratio less than 0.2. When interpreting Figure A1,
Results of ROC among patients from MFB DVT chart review, we can discern that the CRA has no
better clinical utility in predicting DVT than flipping a coin (AUC= 0.5707; sensitivity=54.9%;
specificity=53.4%). When interpreting Figure A2, Adjusted results of receiver operating
characteristic curve (ROC) among patients from MFB DVT chart review, we can distinguish that
the CRA offers a slight improvement over unadjusted results, but still under the AUC threshold
for acceptable use (AUC=0.6139; sensitivity=60.9%; specificity=43.6%). Prior research of
predictive modeling revealed a consistent linear increase in VTE for CRA scores between 1 and
10, while receipt of pharmacologic prophylaxis resulted in a modest decrease in VTE risk (Grant
et al., 2016). Similar to our study, the low overall incidence of venous thromboembolism led to
large estimates of numbers needed to treat to prevent a single VTE event.
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Strengths and Limitations
Our study has several limitations. First, confounding variables associated with receipt of
DVT prophylaxis may have influenced these results, since anticoagulation medications
significantly reduce the risk of a VTE event. In addition, the fact that the data collection was
retrospective, lead to reliance on documentation and imaging studies to confirm VTEs, and
inpatient prophylaxis. Second, the CRA score variable had several missing scores, which
drastically reduced our sample size from 10,782 to 3,091 patients. This also reduced the number
of DVT/PE events that were diagnosed but did not include a CRA score. Third, our study was also
missing general demographic characteristics such as age, gender, and race/ethnicity. Therefore,
we were not able to adjust for these important potential confounding factors in our adjusted models
or provide descriptives on that age, gender, and race/ethnicity characteristics of our study
population.
Despite these limitations, our study has several strengths. Our data was collected through
a review of individual medical records by trained abstractors, which provides a high level of
accuracy within the data itself. Furthermore, the use of pharmacologic prophylaxis may explain
the low incidence of VTE events at MFB indicating the need for continued use based on patient
symptoms and recommendations.
Conclusions and Future Research
The assessment, diagnosis, and treatment of DVT remains a significant problem for
hospitalized patients. The risk of DVT is even more significant when patients are discharged from
the hospital to inpatient rehabilitation facilities. These patients can have multiple risk factors that
predispose them to a DVT or PE event. A variety of prophylaxis strategies can be used to decrease
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the risk of developing DVT. The method of prophylaxis used should be based on individual patient
characteristics.
Screening assessments that have been validated and provide high positive predicative value
in acute-care settings are not always the most applicable assessments to use for the inpatient
rehabilitation patient population. While the CRA has low diagnostic accuracy in predicting true
positive rates of DVT at MFB, this does not affect the long-term outcome of evaluating and
choosing another screening tool or option for assessing DVT risk at inpatient admission and
ongoing monitoring for inpatient rehabilitation patients. Further research is needed to assess what
other complimentary or separate screening measures may be used to provide better diagnostic
accuracy for this unique patient population. such as compression ultrasounds, or D-dimer tests.
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Appendix A
Table A1
Medical service, medications, ambulation, and prophylaxis use among patients from MFB DVT chart review
(n=3,087)
Variables
Medical Service
Amputee
Brain Injury
Cardiac
Spinal
Stroke
Orthopedics
Other
Anticoagulant Medications Received
Enoxaparin
Apixabin
Heparin
Warfarin
Rivaroxaban
Fondaparin
Dabigatran
None
Discharge Location
Home
Home with Health Care
Skilled Nursing Facility
Acute-Care Hospital
Other
Receiving Prophylaxis
Yes
No
Receiving Anticoagulation
Yes
No
DVT/PE
DVT
PE
Neither
Caprini Risk Score
0-1
2
3-4
≥5
b

Frequency, n

Percent, %

165
330
137
672
645
165
975

5.34
10.68
4.43
21.75
20.87
5.34
35.98

1583
332
436
185
96
9
13
437

51.21
10.74
14.11
5.99
3.11
0.29
0.42
14.14

1081
1344
177
450
214

38.51
40.23
6.47
14.56
1.20

3048
43

98.61
1.39

2654
437

85.86
14.14

66
16
3009

2.14
0.52
97.25

397
423
825
1446

12.84
13.68
26.69
46.78

Excludes 1 participant missing medical service and 3 participants missing discharge location.
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Table A2
Patient Characteristics by DVT Event Outcome (n=3,087)

DVT
N=66

Outcome
PE
N= 16

Neither
N=3009

Medical Service, n (%)
Amputee
0
0
165 (5.49)
Brain Injury
6 (9.09)
3 (18.75) 321 (10.67)
Cardiac
0 (2.05)
0
137 (4.45)
Spinal
16 (24.25)
2 (12.50) 654 (21.75)
Stroke
7 (10.61)
0
638 (21.21)
Orthopedics
5 (7.58)
2 (12.50) 158 (5.25)
Other
32 (46.42)
9 (56.25) 934 (26.47)
Anticoagulant Medications Received, n (%)
Enoxaparin
32 (48.38)
8 (50.00) 1543 (51.28)
Apixabin
10 (15.15) 2 (12.50) 320 (10.63)
Heparin
8 (12.12)
2 (12.50) 426 (14.16)
Warfarin
10 (15.15)
2 (12.50) 173 (5.75)
Rivaroxaban
5 (7.58)
2 (12.50) 305 ( 3.39)
Fondaparin
0
0
9 (0.30)
Dabigatran
0
0
13 (2.96)
None
1 (1.52)
0
436 (14.49)
Discharge Location, n (%)
Home
21 (31.82) 4 (25.00) 1056 (35.11)
Home with Health Care
27 (40.52) 6 (37.50) 1312 (43.62)
Skilled Nursing Facility
5 (7.58)
1 (6.25)
171 (5.68)
Acute-Care Hospital
13 (19.70) 5 (31.25) 432 (14.36)
Other
0
0
37 (1.23)
Receiving Prophylaxis, n (%)
Yes
66 (100.00) 40 (100.00) 2966 (98.57)
No
0
0
43 (1.43)
Receiving Anticoagulation, n (%)
Yes
65 (98.48)
16 (100.0) 2573 (85.51)
No
1 (1.52)
0
436 (14.49)
Caprini Risk Score, n (%)
0-1
12 (18.18)
5 (31.25) 385 (12.79)
2
1 (1.52)
8 (50.00) 422 (14.02)
3-4
17 (25.76)
1 (6.25)
801 (26.62)
≥5
36 (54.55)
2 (12.50) 1401 (46.56)
Excludes 1 participant missing medical service and 3 participants missing discharge location.
b
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Table A3
Results of Binomial Logistic Regression Examining the Caprini Risk Assessment Score in Predicting
DVT/PE Events Among Patients from MFB DVT Chart Review (n=3,091)
Caprini Risk Score

DVT/PE Event
Unadjusted OR

(95% CI)

0-1 (Low-risk)

1.00

(reference)

2 (Moderate-risk)

0.076

(0.010-0.587)

3-4 (High-risk)

0.961

(0.476-1.943)

≥ 5 (Highest-risk)

1.031

(0.540-1.967)

Abbreviations: Confidence Interval (CI), Deep Vein Thrombosis (DVT), Odds Ratio (OR), Pulmonary
Embolism (PE)
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Figure A1
Results of receiver operating characteristic curve (ROC) among patients from MFB DVT chart review
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Table A4
Results of Adjusted Binary Logistic Regression Examining the Caprini Risk Assessment Score in
Predicting DV/PE Events Among Patients from MFB DVT Chart Review (n=3,087)
Caprini Risk Score

DVT/PE Event
Adjusted OR

a

(95% CI)

0-1 (Low risk)

1.00

(reference)

2 (Moderate risk)

0.073

(0.009-0.565)

3-4 (High risk)

0.922

(0.451-1.882)

≥ 5 (Highest risk)

0.983

(0.983-1.899)

Note. Table excludes 1 participant missing medical service and 3 participants missing discharge location
Abbreviations: Confidence Interval (CI), Deep Vein Thrombosis (DVT), Odds Ratio (OR), Pulmonary
Embolism (PE)
Adjusted for medical service and discharge location.
a
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Figure A2
Adjusted results of receiver operating characteristic curve (ROC) among patients from MFB DVT chart
review

